October 01, 2015
Article
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
Inaccurate Information on Cancer Diagnosis and Treatment Common on Social Media Sites
Small-Town Cancer Team, Big Success
Grief Is Like Swimming
Rick Aiello Dies From Pancreatic Cancer, FDA Approves First Drug to Treat Lymphoma in Dogs and More
